Literature DB >> 10765054

The development of synkinesis after facial nerve paralysis.

M Celik1, H Forta, C Vural.   

Abstract

In this study, the development of clinical synkinesis after facial nerve paralysis (FP) and its relationship to electrophysiological findings were investigated. Thirty-four patients who were examined within the first 5 days after onset of FP and who could also be followed up for at least 4 months were included in the study. Electrophysiological investigations consisted of: (1) recording of the direct responses by facial nerve stimulation at the stylomastoid fossa; (2) recording of the 'synkinetic spread' of the supraorbital nerve reflex to the lower facial muscles; (3) recording of the 'lateral spread responses' by stimulating the mandible and zygomatic branches of the facial nerve. Clinical synkinesis developed in 14 of 18 patients (78%) with a direct response ratio (DRr) of less than 40%. Among the 16 patients with a DRr of 40% or more, synkinesis was observed in 3 cases (18.7%) only. The DRr provided reliable information concerning the development of synkinesis. Forty percent seemed to be a reasonable limit to distinguish the high-risk group for the development of clinical synkinesis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10765054     DOI: 10.1159/000008154

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  11 in total

1.  A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers.

Authors:  Adam Wiener; Khasha Touloei; Bradley P Glick
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

2.  Validation of a new photogrammetric technique to monitor the treatment effect of Botulinum toxin in synkinesis.

Authors:  N T Mabvuure; M-J Hallam; V Venables; C Nduka
Journal:  Eye (Lond)       Date:  2013-05-17       Impact factor: 3.775

3.  Significance of electromyography to predict and evaluate facial function outcome after acute peripheral facial palsy.

Authors:  Maria Grosheva; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503

4.  Too much or too little? A systematic review of postparetic synkinesis treatment.

Authors:  Jodi B Lapidus; Johnny Chuieng-Yi Lu; Katherine B Santosa; Lauren H Yaeger; Carolyn Stoll; Graham A Colditz; Alison Snyder-Warwick
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-10-11       Impact factor: 2.740

5.  Latency shift in compound muscle action potentials during electroneurography in facial palsy.

Authors:  Yusuke Ayani; Shin-Ichi Haginomori; Shin-Ichi Wada; Haruki Nakano; Masashi Hamada; Takahiro Ichihara; Takaki Inui; Yuko Inaka; Akiko Ozaki; Ryo Kawata
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-13       Impact factor: 2.503

Review 6.  Management of synkinesis and asymmetry in facial nerve palsy: a review article.

Authors:  Abbas Ali Pourmomeny; Sahar Asadi
Journal:  Iran J Otorhinolaryngol       Date:  2014-10

7.  Management of Facial Synkinesis with a Combination of BTX-A and Biofeedback: A Randomized Trial.

Authors:  Abbas Ali Pourmomeny; Sahar Asadi; Ahmad Cheatsaz
Journal:  Iran J Otorhinolaryngol       Date:  2015-11

8.  Impact of early eyelid weight placement on the development of synkinesis and recovery in patients with idiopathic facial paralysis.

Authors:  Keon M Parsa; Caroline Rieger; Dara Khatib; Jennifer R White; Jodi Barth; Chad C Zatezalo; Michael J Reilly
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-06-12

9.  Physical therapy for facial nerve paralysis (Bell's palsy): An updated and extended systematic review of the evidence for facial exercise therapy.

Authors:  Amir J Khan; Ala Szczepura; Shea Palmer; Chris Bark; Catriona Neville; David Thomson; Helen Martin; Charles Nduka
Journal:  Clin Rehabil       Date:  2022-07-05       Impact factor: 2.884

10.  Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial.

Authors:  Abbas Ali Pourmomeny; Elham Pourali; Ahamd Chitsaz
Journal:  Iran J Otorhinolaryngol       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.